News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Global Immune Technologies (GIMU.OB) Completes Securities Agreement With Primedical International Limited And Elects New Board Of Directors; New Management Well Positioned To Lead Company To Growth In The Ambulatory Cardiac Monitoring Market



8/15/2006 11:13:19 AM

Global Immune Technologies, Inc. (OTCBB:GIMU) is pleased to advise that it has signed a Securities Exchange Agreement (SEA) proposing a reverse merger with Primedical International Limited (PML). The combined company, to be renamed Primedical International Holdings, Inc. (Primedical), intends to be a leading provider of telemedicine and remote ambulatory monitoring services.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES